Faster Clinical Trial Nods Planned By The UK To Curb Issues
The UK government intends to make clinical trials more accessible in order to re-establish the country's reputation as a favoured location for pioneering research.
In...
Pharma Drugs Gain From Tardigrade Proteins, Says Research
The study of how the microscopic creatures called tardigrades can survive extreme scenarios has led to a significant breakthrough that could go on to...
EMA Keeping A Close Watch On Critical Medicine Shortages
During its meeting in March 2023, the Management Board of the European Medicines Agency (EMA) gave an update on the continued efforts of the...
Pathways Laid Down By The CMS For Drug Price Negotiations
The Centers for Medicare & Medicaid Services issued preliminary instructions on March 15 on how it intends to negotiate medication pricing under Medicare, a...
Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study
The combination of modulator therapies tezacaftor (TEZ) and ivacaftor (IVA) for cystic fibrosis (CF) has shown long-term safety as well as clinical benefit in...
Cell And Gene Therapy Boost With Novel UK Biotech Centres
The National Health Service Blood and Transplant from the UK, which takes care of blood as well as platelet donations as well as organ,...
Monash University In Australia Leads $15M Mitochondrial Clinical Trial Drive
Almost 50 children in Australia are born every year with a devastating mitochondrial disease that has an expected lifespan of just 5 years. In...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...